NewLink Genetics HyperAcute-Pancreas Immunotherapy (algenpantucel-L) has gained European orphan designation. Orphan designation provides NewLink with access to multiple incentives for drug development in EU. Incentives include decreased ...
Tags: algenpantucel-L, NewLink Genetics, HyperAcute-Pancreas Immunotherapy
Pfizer has received positive opinion from the Committee for Human Medicinal Products (CHMP) of the European Medicines Agency for the marketing authorization of axitinib to treat patients with advanced renal cell carcinoma. The European ...
Ventana Medical Systems, a member of the Roche Group, has introduced a fully-automated staining technique, which helps researchers to examine miRNAs and proteins related to cancer in the same section of tumor tissue. Detecting miRNAs and ...
Tags: Ventana Medical Systems, miRNAs, proteins related to cancer
Diagnostic Biosystems (DBS) has launched the Mosaic 360 System with a product offering of novel Multiplex Immunohistochemistry kits and a complementary line of optimized IHC reagents. The company introduces a portfolio of five Mosaic ...
Enzo Biochem, a molecular diagnostics company, has introduced the ColonSentry blood-based risk stratification test to assess a patient's risk of having colorectal cancer. ColonSentry requires a small blood sample and utilizes RNA to ...
Tags: Enzo Biochem, ColonSentry blood-based risk stratification test
Enzo Biochem has received New York State Department of Health approval for ColonSentry RNA expression assay to assess colorectal cancer risk. The ColonSentry test requires only a small blood sample and can thus be easily incorporated as a ...
Tags: Enzo Biochem, ColonSentry test, ColonSentry RNA expression assay
Quest Diagnostics has introduced a molecular cervical cancer test based on National Institutes of Health's TERC gene marker to identify molecular changes to cervical cells that increase the chance of a woman to develop cervical cancer. ...
Tags: cervical cancer TERC test, Quest Diagnostics, TERC results
PerkinElmer has launched a panel of nine new epigenetic research assay kits to trace endogenous histone modifications at the Revolutionaries for Global Health Summit (RGH), San Francisco, US. Hosted by PerkinElmer, RGH Summit shares ...
Tags: PerkinElmer, new reagents, panel of nine new epigenetic research
LabCorp has entered into an agreement to expand sale of Mitomics' prostate core mitomic test (PCMT) throughout the US. Under the agreement, urologists will be able to order Mitomics' PCMT kit, through LabCorp's specialized laboratory ...
Tags: LabCorp, Mitomics'prostate core mitomic test, PCMT, PCMT kit
Absorption Systems has launched new assay for the human breast cancer resistance protein (BCRP) transporter. The new assay will enable drug developers to test new drug candidates for interactions with BCRP, which is involved in drug ...
Tags: Absorption Systems, breast cancer resistance protein transporter
Agendia, a developer of genomic-based diagnostic products, has unveiled ColoPrint microarray-based 18-gene expression signature. The ColoPrint assay provides critical additional information for treatment decisions for stage II colon ...
Tags: ColoPrint, Agendia, colon cancer patients
Abbott will expand the current CE-IVD product labeling for its Vysis ALK Break Apart FISH Probe Kit to allow the test to be marketed in the European Union as a companion diagnostic. The test uses Abbott's proprietary fluorescence in situ ...
Tags: Abbott, anaplastic lymphoma kinase, ALK, FISH technology
GoldenPalace bought the giant piece of underwear from chillisauce as part of a charity auction for the Breast Cancer Campaign’s ‘wear it pink' event. They paid a healthy £3,601 for the bra in the EBay auction which ended ...
Tags: giant piece of innerwear, chillisauce, Breast Cancer Campaign
The Supreme Court was informed that one of the reasons for not extending the leasing licence to the Tethyan Copper Company was the absence of an environmental protection certificate in the Reko Diq project. Mr Amanullah Kinrani ...
Tags: TCC, Tethyan Copper Company, Barrick Gold and Antofagasta Minerals
Kyowa Hakko Kirin, Orexo's partner, has filed a new drug application (NDA) seeking Japanese approval for KW-2246 as cancer pain medication. The sublingual formulation of fentanyl earlier gained approval in US, EU and Canada as cancer ...
Tags: new drug application, cancer pain medication, pharmaceutical product